Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Separation and purification method and kit for fetal nucleated red blood cells

A technique for separating and purifying nuclear red blood cells, which is applied in the field of cell biology detection, can solve the problems of fetal cell enrichment, small number of separations, no substantive breakthroughs, limited range of diseases, etc., and achieve tolerance to separation and washing operations, The effect of avoiding a large amount of loss and improving the purity

Active Publication Date: 2016-11-16
SHANDONG YADA PHARMA
View PDF12 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] To sum up, the current domestic and foreign researches in this area all have the problems of enrichment of fetal cells, small number of separations, insufficient purity, complex operation process, and the scope of diseases applied to prenatal diagnosis is very limited, making this work insubstantial. sexual breakthrough

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Embodiment 1: Separation and purification of fetal NRBC

[0066] Take 3ml of peripheral venous blood from pregnant women whose pregnancy is 16-18 weeks into heparin anticoagulant blood collection tubes, centrifuge at 500g for 5 minutes to remove plasma, and add 8ml of PBS (NaCl 137mmol / L, KCl 2.7mmol / L, NaCl 2.7mmol / L, NaCl 2 HPO 4 4.3mmol / L, KH 2 PO 4 1.4mmol / L, pH7.2) prepared 1% (w / v) NH 4 Cl solution, mix well, place in ice bath for 10 minutes, lyse red blood cells, centrifuge at 500g for 5 minutes to remove supernatant, shake the pellet to resuspend the cells. Then add 1ml of 3% glutaraldehyde solution prepared in PBS, and fix the cells for 10 minutes. Fully wash the cells twice with 10 ml of normal saline, resuspend the cells with 1 ml of normal saline, add 10E+8CD45 antibody-labeled magnetic beads (Miltenyl biotech, serial number 130-045-801), mix well for 15 minutes, and place on a magnetic separation rack Separate the cells, transfer the liquid part to a...

Embodiment 2

[0068] Take 3ml of peripheral venous blood from a pregnant woman whose pregnancy is 16-18 weeks into a heparin anticoagulant blood collection tube, centrifuge at 500g for 5 minutes to remove plasma, add 8ml of 1% NH prepared in PBS to the blood cell pellet 4 Cl solution, mix well, place in ice bath for 10 minutes, lyse red blood cells, centrifuge at 500g for 5 minutes to remove supernatant, shake the pellet to resuspend the cells. Then add 1ml of 3% glutaraldehyde solution prepared in PBS to fix the cells for 10 minutes. Fully wash the cells twice with 10 ml of normal saline, resuspend the cells with 1 ml of normal saline, add 10E+8CD45 antibody-labeled magnetic beads (Miltenyl biotech, serial number 130-045-801), mix well for 15 minutes, and place on a magnetic separation rack Separate the cells, transfer the liquid part to a test tube containing 10E+6CD71 antibody-labeled magnetic beads (Miltenyl biotech, serial number 130-046-201), mix well for 15 minutes, separate the cell...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a separation and purification method for fetal nucleated red blood cells. The method is characterized by comprising the following steps: carrying out cracking treatment on nuclear-free red blood cells in a peripheral venous blood sample of a pregnant woman; adding a cell immobilization reagent in the blood sample subjected to cracking treatment; carrying out cell separation on the blood sample subjected to cell immobilization so as to obtain the fetal nucleated red blood cells. The invention further relates to a kit for separating and purifying the fetal nucleated red blood cells from the peripheral venous blood sample of the pregnant woman. According to the method and the kit, the yield and purity of separating of target cells are greatly improved, and a good foundation is laid for subsequent various analyses.

Description

technical field [0001] The invention belongs to the field of cell biology detection, and in particular relates to a separation and purification method and kit for fetal nucleated red blood cells. The invention can be applied to prenatal genetic or chromatin screening. Background technique [0002] With the development of modern medicine, the advancement of medical technology, and the development of medical and health care, infectious diseases have been better controlled, and people's average life expectancy has been continuously extended. There is no effective treatment, and it is becoming more and more important in the diseases that seriously threaten people's health, which has brought great mental burden and economic loss to the family and society. Therefore, prenatal diagnosis is carried out to avoid the birth of children as a control genetic disease. It is an important way to prevent the occurrence of diseases, reduce the genetic load of the population, and improve the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/073C12N5/078
CPCC12N5/0641C12N2509/00C12N5/00G01N33/68
Inventor 夏庆杰杨林杨雪飞
Owner SHANDONG YADA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com